PALI

Palisade Bio, Inc. Common Stock

$2.08 -1.89%

Recent alerts on PALI

All signals →

News Bears are Losing Control Over Palisade Bio (PALI), Here's Why It's a 'Buy' Now

Short volume Short volume 51% of volume (6.8σ)

Insider trade Sale by John David Finley (CEO, CFO)

Insider trade Sale by Mitchell Lawrence Jones (Chief Medical Officer)

Insider trade Purchase by Donald Allen Williams

Insider trade Purchase by Donald Allen Williams

News Palisade Bio Announces Cancellation of Special Meeting of Stockholders

Get push alerts for PALI

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS